<?xml version="1.0" encoding="UTF-8"?>
<record
    xmlns:xsi="https://www.w3.org/2001/XMLSchema-instance"
    xsi:schemaLocation="https://www.loc.gov/MARC21/slim https://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd"
    xmlns="https://www.loc.gov/MARC21/slim">

  <leader>07428nam a2200301   4500</leader>
  <controlfield tag="001">387073</controlfield>
  <datafield tag="010" ind1=" " ind2=" ">
    <subfield code="a">0 7453 2508 4</subfield>
  </datafield>
  <datafield tag="090" ind1=" " ind2=" ">
    <subfield code="a">387073</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">20080930d2006       y0pory50      ba</subfield>
  </datafield>
  <datafield tag="101" ind1=" " ind2=" ">
    <subfield code="a">eng</subfield>
  </datafield>
  <datafield tag="200" ind1=" " ind2=" ">
    <subfield code="a">Global corruption report 2006</subfield>
    <subfield code="b">Recurso eletr&#xF3;nico</subfield>
    <subfield code="e">[special focus - corruption and health]</subfield>
  </datafield>
  <datafield tag="210" ind1=" " ind2=" ">
    <subfield code="a">London ; Ann Arbor, MI</subfield>
    <subfield code="c">Pluto</subfield>
    <subfield code="d">2006</subfield>
  </datafield>
  <datafield tag="215" ind1=" " ind2=" ">
    <subfield code="a">1 CD-ROM</subfield>
    <subfield code="d">12 cm</subfield>
  </datafield>
  <datafield tag="300" ind1=" " ind2=" ">
    <subfield code="a">Ficheiro de 6,63 Mb em formato pdf (378 f.). Tamb&#xE9;m dispon&#xED;vel atrav&#xE9;s de: https://www.transparency.org/publications/gcr/download_gcr/download_gcr_2006.Acedido em: 30 de Setembro de 2008.</subfield>
  </datafield>
  <datafield tag="330" ind1=" " ind2=" ">
    <subfield code="a">Acknowledgements. Preface (David Nussbaum). Foreword (Mary Robinson). Executive summary (Transparency International). Part one: Corruption and health - 1 The causes of corruption in the health sector: a focus on health care systems - Why are health systems prone to corruption? (William D. Savedoff and Karen Hussmann). A tale of two health systems (William D. Savedoff). Corruption in health care systems: the US experience (Malcolm K. Sparrow). Corruption in Cambodia&#x2019;s health sector (Lisa Prevenslik-Takeda). 2 The scale of the problem - Case study: Grand corruption in Costa Rica (Emilia Gonz&#xE1;lez). Measuring corruption in the health sector: what we can learn from public expenditure tracking and service delivery surveys in developing countries (Magnus Lindelow, Inna Kushnarova and Kai Kaiser). Local-level corruption hits health service delivery in the Philippines (Omar Azfar and Tugrul Gurgur). Corruption is bad for your health: findings from Central and Eastern Europe (Richard Rose). &#x2018;Citizens&#x2019; audit&#x2019; in Mexico reveals paper trail of corruption (Helena Hofbauer). Fighting fraud and corruption in Britain&#x2019;s National Health Service (Jim Gee). 3 Corruption in hospitals - Corruption in hospital administration (Taryn Vian). Cash registers inject transparency &#x2013; and revenue &#x2013; into Kenya&#x2019;s Coast Provincial General Hospital (Taryn Vian). Hospital waiting lists open for scrutiny in Croatia (Ana First). No bribes for healthy business: India&#x2019;s Transasia Biomedicals (Michael Smith). 4 Informal payments for health care - Paying for &#x2018;free&#x2019; health care: the conundrum of informal payments in post-communist Europe (Sara Allin, Konstantina Davaki and Elias Mossialos). Gift, fee or bribe? Informal payments in Hungary (P&#xE9;ter Ga&#xE1;l). Informal payments take a toll on Moroccan patients (Azeddine Akesbi, Siham Benchekroun and Kamal El Mesbahi). 5 Corruption in the pharmaceutical sector - Pharmaceuticals and corruption: a risk assessment (Jillian Clare Cohen). US pharmaceutical company fined for payments to charity headed by Polish health official (Transparency International). The corrupting influence of money in medicine (Jerome P. Kassirer). Promoting trust and transparency in pharmaceutical companies: an industry perspective (Harvey Bale). Fighting corruption: the role of the medical profession (John R. William). The fight against counterfeit drugs in Nigeria (Dora Akunyili). Corruption in the Ministry of Public Health, Thailand (Stuart Cameron). Malpractice in the Office of the Drug Controller in Karnataka, India (Stuart Cameron). 6 Corruption and HIV/AIDS - The link between corruption and HIV/AIDS (Liz Tayler and Clare Dickinson). Accountability in a time of crisis: corruption and the Global Fund (Toby Kasper). Corruption in Kenya&#x2019;s National AIDS Control Council (Kipkoech Tanui and Nixon Ng&#x2019;ang&#x2019;a). Part two: Country reports. 7 Lessons learned from anti-corruption campaigns around the world (Cobus de Swardt). 8 Country reports: Algeria (Djilali Hadjadj ); Bangladesh (Iftekhar Zaman, Sydur Rahman and Abdul Alim); Bolivia (Guillermo Pou Munt Serrano); Brazil (Ana Luiza Fleck Saibro); Burkina Faso (Luc Damiba); Cameroon (Jean-Bosco Talla and Maurice Ngu&#xE9;fack ); China (Guo Yong and Liao Ran); Costa Rica (Roxana Salazar); Croatia (Ana First); Ecuador (Andr&#xE9;s Tobar); Finland (Santeri Eriksson); France (Antoine Genevois); Georgia (Daria Vaisman); Greece (Markella Samara); Guatemala (Alejandro Urizar); Ireland (Elaine Byrne); Israel (Doron Navot); Japan (Transparency International Japan); Kazakhstan (Sergey Zlotnikov ); Kenya (Wachira Maina and Noelina Nabwire); Kuwait (Kuwait Economic Society); Kyrgyzstan (Aigul Akmatjanova); Malaysia (Mehrun Siraj and Sunita Chima); Morocco (Azeddine Akesbi, Siham Benchekroun, Kamal El Mesbahi, Rachid Filali Meknassi and Mich&#xE8;le Zirari); Nepal (Rama Krishna Regmee); New Zealand (Shane Cave); Nicaragua (Roberto Courtney); Panama (Ang&#xE9;lica Mayt&#xED;n Justiniani); Papua New Guinea (Transparency International Papua New Guinea); Peru (Samuel Rotta Castilla and Leonardo Narvarte Olivares); Poland (Julia Pitera); Romania (Adrian Savin); Serbia (Nemanja Nenadic); Slovakia (Emilia Sic&#xE1;kov&#xE1;-Beblav&#xE1;); South Africa (Ayesha Kajee); South Korea (Geo-Sung Kim); Spain (Manuel Villoria); Sri Lanka (Anushika Amarasinghe); Switzerland (Jeffrey Nilsen, Anne Schw&#xF6;bel and Stefanie Teickner); Uganda (Charles Mubbale and Paul Onapa); Ukraine (Transparency International); United Kingdom (Transparency International - UK); United States of America (Nancy Izzo Jackson with Michael Johnston, Mark Glaze, Holly Gregory and Chris Yukins); Vanuatu (Anita Jowitt); Venezuela (Transparencia Venezuela). Part three: Research on corruption. 9. Introduction (Robin Hodess). 10. Ten years of the CPI: determining trends (Johann Graf Lambsdorff). 11. Corruption Perceptions Index 2005 (Johann Graf Lambsdorff). 12. Governance matters IV: new data, new challenges (Daniel Kaufmann, Aart Kraay and Massimo Mastruzzi). 13. Corruption in the United States of America (Edward Glaeser and Raven Saks). 14. Transparency and its impact on financial fragility (Saadia Zahidi). 15. Budget transparency survey (Pamela Gomez). 16. Beyond the rhetoric: measuring revenue transparency in the oil and gas industry (Elizabeth Lort-Phillips and Vanessa Herringshaw). 17. Benchmarking corporate reputation: an incentive for good anti-corruption practice (Transparencia Mexicana). 18. Officials&#x2019; asset declaration laws: do they prevent corruption? (Ranjana Mukherjee and Omer Gokcekus). 19. Tax evasion, fines and corruption in Mozambique (Ralf Lanwehr). 20. The V4 index: corruption propensity in four Visegr&#xE1;d capitals (Michal &#x160;ticka). 21. Efficiency of federal transfers to municipalities in Brazil (Marcos Jose Mendes). 22. Integrity Index for Public Institutions: evaluating Colombia&#x2019;s health sector (Transparencia por Colombia). 23. Corruption in the public health service in Bangladesh (Iftekhar Zaman and Alim Abdul). 24. Governance in Bulgaria&#x2019;s pharmaceutical selection and procurement systems (Patrick Meagher). 25. Survey research sheds light on Latin Americans&#x2019; experience with corruption (Eric Kite and Margaret Sarles). 26. Corruption in Palestinian society (TI Palestine/the Coalition for Accountability and Integrity - AMAN).</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="a">CORRUP&#xC7;&#xC3;O</subfield>
    <subfield code="9">229145</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="a">SUBORNO</subfield>
    <subfield code="9">301519</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="a">ESTABELECIMENTO HOSPITALAR</subfield>
    <subfield code="9">104896</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="a">IND&#xDA;STRIA FARMAC&#xCA;UTICA</subfield>
    <subfield code="9">270722</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="a">COOPERA&#xC7;&#xC3;O INTERNACIONAL</subfield>
    <subfield code="9">229150</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="a">RELAT&#xD3;RIO ANUAL</subfield>
    <subfield code="9">299235</subfield>
  </datafield>
  <datafield tag="710" ind1=" " ind2=" ">
    <subfield code="a">TRANSPARENCY INTERNATIONAL</subfield>
    <subfield code="9">189029</subfield>
  </datafield>
  <datafield tag="955" ind1=" " ind2=" ">
    <subfield code="x">Oferta</subfield>
  </datafield>
  <datafield tag="995" ind1=" " ind2=" ">
    <subfield code="1">0</subfield>
    <subfield code="4">PJCD_110_000000000000000</subfield>
    <subfield code="5">2022-06-06</subfield>
    <subfield code="6">PJCD110</subfield>
    <subfield code="9">417885</subfield>
    <subfield code="a">PJ</subfield>
    <subfield code="c">PJ</subfield>
    <subfield code="f">PJ1CD110_20</subfield>
    <subfield code="k">PJCD110</subfield>
    <subfield code="n">2022-06-06</subfield>
    <subfield code="o">0</subfield>
    <subfield code="r">MO</subfield>
    <subfield code="x">Oferta</subfield>
  </datafield>
</record>
